loading page

Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Per Protocol Analysis, and Exploratory Endpoints
  • +3
  • Jonathan Bernstein,
  • Umesh Singh,
  • Marepalli Rao,
  • Karen Berendts,
  • Xiang Zhang,
  • Diya Mutasim
Jonathan Bernstein
University of Cincinnati
Author Profile
Umesh Singh
University of Cincinnati College of Medicine
Author Profile
Marepalli Rao
University of Cincinnati College of Medicine
Author Profile
Karen Berendts
Bernstein Clinical Research Center
Author Profile
Xiang Zhang
University of Cincinnati College of Medicine
Author Profile
Diya Mutasim
University of Cincinnati College of Medicine
Author Profile

Peer review status:Published

26 Oct 2020Submitted to Allergy
27 Oct 2020Submission Checks Completed
27 Oct 2020Assigned to Editor
29 Oct 2020Reviewer(s) Assigned
15 Nov 2020Review(s) Completed, Editorial Evaluation Pending
29 Nov 20201st Revision Received
30 Nov 2020Submission Checks Completed
30 Nov 2020Assigned to Editor
01 Dec 2020Reviewer(s) Assigned
10 Dec 2020Review(s) Completed, Editorial Evaluation Pending
10 Dec 2020Editorial Decision: Accept
Apr 2021Published in Allergy volume 76 issue 4 on pages 1277-1280. 10.1111/all.14713